Rick van Leeuwen

855 total citations
11 papers, 599 citations indexed

About

Rick van Leeuwen is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Rick van Leeuwen has authored 11 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Rick van Leeuwen's work include MicroRNA in disease regulation (6 papers), Viral Infections and Immunology Research (4 papers) and Cardiac Fibrosis and Remodeling (3 papers). Rick van Leeuwen is often cited by papers focused on MicroRNA in disease regulation (6 papers), Viral Infections and Immunology Research (4 papers) and Cardiac Fibrosis and Remodeling (3 papers). Rick van Leeuwen collaborates with scholars based in Netherlands, Belgium and Spain. Rick van Leeuwen's co-authors include Stéphane Heymans, Paolo Carai, Wouter Verhesen, Blanche Schroen, Georg Summer, Mark R. Hazebroek, Maarten F. Corsten, Anna‐Pia Papageorgiou, Anna Papageorgiou and Arantxa González and has published in prestigious journals such as Circulation Research, Hypertension and European Heart Journal.

In The Last Decade

Rick van Leeuwen

10 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rick van Leeuwen Netherlands 8 363 286 236 89 66 11 599
Wouter Verhesen Netherlands 12 554 1.5× 341 1.2× 411 1.7× 102 1.1× 97 1.5× 17 874
Vijay Divakaran United States 7 290 0.8× 225 0.8× 194 0.8× 50 0.6× 27 0.4× 17 489
Ludovic Malvaux Belgium 6 414 1.1× 215 0.8× 318 1.3× 149 1.7× 46 0.7× 7 671
Yamin Su China 11 457 1.3× 132 0.5× 349 1.5× 71 0.8× 59 0.9× 29 655
Xi A China 3 351 1.0× 157 0.5× 172 0.7× 76 0.9× 96 1.5× 4 486
Mark Roufaiel Canada 5 252 0.7× 73 0.3× 154 0.7× 60 0.7× 132 2.0× 7 411
Pía Boza Chile 11 179 0.5× 184 0.6× 55 0.2× 69 0.8× 77 1.2× 12 409
Bingyuan Wu China 13 184 0.5× 143 0.5× 83 0.4× 84 0.9× 33 0.5× 29 435
Vicken W. Chan Hong Kong 8 266 0.7× 81 0.3× 129 0.5× 131 1.5× 116 1.8× 8 497
Michael Praus Germany 12 280 0.8× 102 0.4× 273 1.2× 139 1.6× 27 0.4× 19 691

Countries citing papers authored by Rick van Leeuwen

Since Specialization
Citations

This map shows the geographic impact of Rick van Leeuwen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick van Leeuwen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick van Leeuwen more than expected).

Fields of papers citing papers by Rick van Leeuwen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick van Leeuwen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick van Leeuwen. The network helps show where Rick van Leeuwen may publish in the future.

Co-authorship network of co-authors of Rick van Leeuwen

This figure shows the co-authorship network connecting the top 25 collaborators of Rick van Leeuwen. A scholar is included among the top collaborators of Rick van Leeuwen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick van Leeuwen. Rick van Leeuwen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Simmonds, Steven J., et al.. (2025). CCR2+ monocyte-derived macrophages drive cardiac hypertrophy in early HFpEF. American Journal of Physiology-Heart and Circulatory Physiology. 329(1). H109–H123. 2 indexed citations
2.
Rienks, Marieke, Paolo Carai, Wouter Verhesen, et al.. (2018). SPARC preserves endothelial glycocalyx integrity, and protects against adverse cardiac inflammation and injury during viral myocarditis. Matrix Biology. 74. 21–34. 26 indexed citations
3.
Lumens, Joost, Paolo Carai, Rick van Leeuwen, et al.. (2018). AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism. Molecular Therapy — Nucleic Acids. 14. 424–437. 35 indexed citations
4.
Heggermont, Ward, Paolo Carai, Marieke Rienks, et al.. (2017). Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation. Matrix Biology. 66. 110–124. 40 indexed citations
5.
Verjans, Robin, T. J. Peters, Javier Beaumont, et al.. (2017). MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload–Induced Heart Failure. Hypertension. 71(2). 280–288. 133 indexed citations
6.
Rienks, Marieke, Anna Papageorgiou, Kristiaan Wouters, et al.. (2016). A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis. Cellular and Molecular Life Sciences. 74(8). 1511–1525. 29 indexed citations
7.
Corsten, Maarten F., Ward Heggermont, Anna‐Pia Papageorgiou, et al.. (2015). The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis. European Heart Journal. 36(42). 2909–2919. 93 indexed citations
8.
Peters, T. J., Mitchell Bijnen, Rick van Leeuwen, et al.. (2014). P69The microRNA-221/222 family is differentially regulated in cardiac disease and counteracts pressure overload-induced cardiac remodeling in mice. Cardiovascular Research. 103(suppl 1). S11.3–S11.
9.
Aelst, Lucas Van, Sandra Voss, Paolo Carai, et al.. (2014). Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening. Circulation Research. 116(3). 425–436. 72 indexed citations
10.
Heggermont, Ward, Maarten F. Corsten, Hendrik Jan Thibaut, et al.. (2013). The microRNA 221/222 cluster controls CVB3-induced myocarditis: could tiny microRNAs explain adverse inflammation in the heart?. European Heart Journal. 34(suppl 1). 5866–5866. 1 indexed citations
11.
Corsten, Maarten F., Anna Papageorgiou, Wouter Verhesen, et al.. (2012). MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis. Circulation Research. 111(4). 415–425. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wouter Verhesen Breakdown of academic impact, for papers by Vijay Divakaran Breakdown of academic impact, for papers by Ludovic Malvaux Breakdown of academic impact, for papers by Yamin Su Breakdown of academic impact, for papers by Xi A Breakdown of academic impact, for papers by Mark Roufaiel Breakdown of academic impact, for papers by Pía Boza Breakdown of academic impact, for papers by Bingyuan Wu Breakdown of academic impact, for papers by Vicken W. Chan Breakdown of academic impact, for papers by Michael Praus
Rankless by CCL
2026